ACIU Research and Charts

ACIU - AC Immune SA (Healthcare: Biotechnology)

Projected Earnings Date: 2024-07-30 (Delayed quote data 2025-04-03)

Last 1.77	Change ⇓ -0.11 (-5.85%)	Volume 229,996
	Open 1.82	High 1.86	Low 1.77

8EMA (Daily) 1.91	40EMA (Daily) 2.28	50EMA (Daily) 2.35	STO (Daily) 5.989	MACD Hist (Daily) -0.045
8EMA (Weekly) 2.223	40EMA (Weekly) 2.84	50EMA (Weekly) 2.91	STO (Weekly) 4.523	MACD Hist (Weekly) -0.173


Company Profile
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.